search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
SURGICAL S I T E INF ECTION


Time to act on surgical site infections


Nick Rothwell warns that we do not yet have a true picture of SSI prevalence in the UK and, without this, we will never fully understand the scale of the problem with which we are dealing. He highlights a new report, Time to Act, which aims to raise awareness of the key issues.


COVID-19 continues to significantly impact every aspect of our lives. In particular, it has brought the importance of infection prevention to the forefront of public consciousness. We wear face coverings to buy groceries and when we use public transport, we are reminded to regularly wash our hands for two minutes, and we stay a safe distance away from our family and friends to prevent transmission. As the general public has become more aware of the importance of infection prevention measures in their day-to-day lives, we must also consider what more can be done to support the NHS to enhance the way in which it prevents infections – including in the operating theatre.


The NHS has been on the frontline in the battle against the virus, while also managing its unintended consequences. From later diagnoses of conditions such as


cancer, through to increased waiting times or cancellations of elective surgery, the pressure on the service has never been greater in its 72 years of existence. It is down to all of us to support the NHS and our brilliant healthcare professionals (HCPs) to help manage these pressures and overcome the challenges ahead, and that includes making surgeries as safe as possible for patients.


Time to act


Surgical site infections (SSIs) are a common type of healthcare-associated infection (HCAI) that can significantly impact both healthcare systems and patients.1


SSIs can


lead to extended hospital stays – resulting in additional cost burden for healthcare providers – and can contribute to antibiotic resistance. While there is no agreed figure for the total cost of SSIs to the NHS, each infection has been estimated to cost the NHS a staggering


£10,0002 to £100,000 per patient.3


The impact of these infections on patients can be devastating. One in twenty patients will contract an SSI,4


and these patients


As a result, in some instances, these infections can be life changing. Patients may go on to lose their jobs, their relationships, and sometimes, their homes. SSIs can be disfiguring and, in certain cases, the infection can never be cured, resulting in amputation or morbidity.6 However, the positive news is that up to 60% of SSIs are preventable.7


will experience pain and discomfort. It can result in delays in returning home from hospital, with an average hospital stay of 12 days.5


Steps can


be taken across a patients’ journey through surgery – before, during and after – to ensure their risk of infection is lowered. Despite clear evidence and guidelines, including from the World Health Organization (WHO) and the National Institute for Health and Care Excellence (NICE), infection rates in the UK remain high. It is critical that we understand why this is the case, and what measures might support us to prevent more of these infections.


Understanding the full picture of SSIs in the UK


In order to do this, Mölnlycke has published a report – Time to Act: A State of the Nation report on Surgical Site Infections – which looks at the scale of the challenge of tackling SSIs in the UK, with the valuable support and insights of leading clinicians in the field. The first-of-its-kind report provides a detailed picture of SSI rates in the UK, and their impact on patients, clinicians and the NHS. In examining how to reduce the impact of SSIs, we reviewed some of the best practice taking place from both within the UK and around the world. We spoke to frontline clinicians, including Professor Mike Reed, a consultant trauma


JANUARY 2021 WWW.CLINICALSERVICESJOURNAL.COM l 59





Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80